Sicart Associates’s C.H. Robinson CHRW Stock Holding History

Sicart Associates’s Portfolio CHRW Stock Details CHRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,500	Closed	-$549K	–	92
2016 Q4	$549K	Buy	+7,500	New	+$543K	0.38%	68

Other funds holding CHRW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sicart Associates's CHRW Position: Q1 2017 in Review

Sicart Associates sold out of C.H. Robinson (CHRW) in Q1 2017, closing a stake of 7,500 shares — an estimated $549K sold.

Sicart Associates first reported a position in CHRW in Q4 2016 and held it in 1 quarter. The position peaked at $549K in Q4 2016. 510 funds tracked by Wall St. Rank hold CHRW as of Q1 2017.

Sicart Associates reported no remaining C.H. Robinson position as of Q1 2017 after selling out during the quarter.
Sicart Associates sold 7,500 C.H. Robinson shares in Q1 2017, an estimated $549K.
Sicart Associates first reported a position in C.H. Robinson in Q4 2016 and held it in 1 quarter.
Sicart Associates's C.H. Robinson position peaked at $549K in Q4 2016.
510 funds tracked by Wall St. Rank held C.H. Robinson as of Q1 2017.

Based on Sicart Associates's 13F filing for Q1 2017, filed 10 Apr 2017.